NSAIDs to Prevent Breast Cancer Recurrence? An Unanswered Question
- PMID: 29554350
- PMCID: PMC6136929
- DOI: 10.1093/jnci/djy049
NSAIDs to Prevent Breast Cancer Recurrence? An Unanswered Question
Comment on
-
Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.J Natl Cancer Inst. 2018 Sep 1;110(9):1003-1008. doi: 10.1093/jnci/djy017. J Natl Cancer Inst. 2018. PMID: 29554282 Free PMC article. Clinical Trial.
References
-
- Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;3769754:1741–1750. - PubMed
-
- Bertagnolli MM, Eagle CJ, Zauber AG, et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med. 2006;3559:873–884. - PubMed
-
- Solomon SD, McMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;35211:1071–1080. - PubMed
-
- Chen WY, Holmes MD.. Role of aspirin in breast cancer survival. Curr Oncol Rep. 2017;197:48. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
